Pivotal Corporation, the Seattle start-up responsible for disrupting the wearable fitness marketplace with its $12 Pivotal Living Band, is pleased to announce pre-order availability for the Pivotal Living Smart Scale, a smarter scale with an even smarter price. Available for $39.95, just a fraction of the cost of most smart scales on the market, the elegant and efficient smart scale integrates seamlessly with the Pivotal Living app to provide a more intelligent way to manage body weight and overall health.
“Our mission has always been to spark a movement toward proactive health and wellness through affordable and powerful, personal health technology,” said David Donovick, CEO for Pivotal Corporation. “We are very proud to introduce a feature-rich smart scale to our family of products and software, and are thrilled to be able to offer it to our members at a pizza-dinner price!”
Using advanced bioimpedance technology, the Pivotal Living Smart Scale accurately measures key body weight and body fat percentage factors, helping people lose weight and stay healthy. Designed to help users identify when they are burning fat, building muscle and losing weight, the sleek smart scale displays weight on the scale’s easy-to-read LCD display screen and, when synced to the Pivotal Living mobile app, sends additional weight and body details. The scale’s four load sensors accurately assess body composition measurements based on weight and height data stored within the app. Working together, the scale and app measure and track.
To view the multimedia release go to:
http://www.multivu.com/players/English/7668051-pivotal-living-bluetooth-smart-scale/
If there’s one thing that socially responsible businesses have learned, it’s that they can’t go at it alone. Whether it’s implementing responsible sourcing initiatives or creating a positive corporate model to make an impact on sustainability, there is strength in numbers. So where did Ben & Jerry’s turn for help and inspiration for its latest ice cream flavor? Colorado-based New Belgium Brewing. Never has the phrase “polishing off a pint” been so perfectly poised in any partnership for a delicious double-entendre.
Collectively committed to making a better impact in their global communities, the two B Corp companies proudly introduced Salted Caramel Brown-ie Ale ice cream, which will be featured in Ben & Jerry’s Scoop Shops as well as in pints across the country as a Limited Batch flavor this fall (MSRP $4.89). The concoction consists of New Belgium Brown Ale Ice Cream with Salted Caramel Swirls and Fudge Brownies. The ice cream, arriving on shelves this month, was unveiled Wednesday evening at a Washington D.C. launch “Brew-Ha-Ha” in the confines of the historic Howard Theatre. The launch event was heralded as “a night of music, climate activism, beer, and ice cream.” Musicians Galactic and Dr. Dog performed at the unveiling of Ben & Jerry’s newest ice cream flavor to highlight climate activism.
To view the multimedia release go to:
http://www.multivu.com/players/English/7648451-ben-and-jerry-s-new-belgium-brewery/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Leading Scotch Whisky brand LABEL 5 reveals an exclusive partnership with bartenders around the world who have created innovative and tasty cocktails with LABEL 5 Classic Black. In addition to this digital campaign called “WHISKY CONFIDENTIAL”, LABEL 5 announces being partner of the IBA’s World Cocktail Championships for 2015.
With its videos, LABEL 5 invites its consumers to enter into private and trendy bars to get exclusive cocktail recipes imagined by the bartenders.
Reflecting the latest whisky-based cocktails trends in Shanghai, New York and London, LABEL 5 stays true to its international and contemporary positioning while offering a new experience that enhances the smoothness and balanced character of its core reference LABEL 5 Classic Black.
To view the multimedia release go to:
http://www.multivu.com/players/English/7655951-label5-whisky-confidential-campaign/
Leading Scotch Whisky brand LABEL 5 reveals an exclusive partnership with bartenders around the world who have created innovative and tasty cocktails with LABEL 5 Classic Black. In addition to this digital campaign called “WHISKY CONFIDENTIAL”, LABEL 5 announces being partner of the IBA’s World Cocktail Championships for 2015.
With its videos, LABEL 5 invites its consumers to enter into private and trendy bars to get exclusive cocktail recipes imagined by the bartenders.
Reflecting the latest whisky-based cocktails trends in Shanghai, New York and London, LABEL 5 stays true to its international and contemporary positioning while offering a new experience that enhances the smoothness and balanced character of its core reference LABEL 5 Classic Black.
To view the multimedia release go to:
http://www.multivu.com/players/English/7655951-label5-whisky-confidential-campaign/
Leading Scotch Whisky brand LABEL 5 reveals an exclusive partnership with bartenders around the world who have created innovative and tasty cocktails with LABEL 5 Classic Black. In addition to this digital campaign called “WHISKY CONFIDENTIAL”, LABEL 5 announces being partner of the IBA’s World Cocktail Championships for 2015.
With its videos, LABEL 5 invites its consumers to enter into private and trendy bars to get exclusive cocktail recipes imagined by the bartenders.
Reflecting the latest whisky-based cocktails trends in Shanghai, New York and London, LABEL 5 stays true to its international and contemporary positioning while offering a new experience that enhances the smoothness and balanced character of its core reference LABEL 5 Classic Black.
To view the multimedia release go to:
http://www.multivu.com/players/English/7655951-label5-whisky-confidential-campaign/
The S90 marks a giant step forward for Volvo Cars. The Swedish car maker is better known for its SUVs and estates, but with the launch of the S90 Volvo is clearly intent on shaking up the premium sedan segment with its distinctive executive class sedan.
Equipped with a host of new technologies ranging from cutting edge safety to cloud-based apps and services, the S90 is further proof of the Swedish brand’s continuing transformation.
“With the launch of the XC90 we made a clear statement of intent. We are now clearly and firmly in the game. With $11 USD billion of investment over the past five years we have not only reimagined what Volvo Cars can be – we are now delivering on our promise of a resurgent and relevant Volvo Cars brand,” said Håkan Samuelsson, President & CEO, Volvo Car Group.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7702651-volvo-stakes-its-claim-with-the-S90/
For the first time a YSL skincare product joins the collection at a science museum. Glycobiology, the science of glycans applied to the skin and cosmetics pioneered by YSL Beauté with FOREVER YOUTH LIBERATOR SERUM, is now part of the Berlin Museum‘s newly inaugurated permanent exhibition dedicated to the central role played by glycans in the realm of life.
After being closed for renovations for three years, the Berlin-based Sugar Museum has reopened as part of the Deutsches Technikmuseum with an expanded exhibition about sugars: “Sugars and Beyond! Food – Matter – Energy”, from November 26, 2015. In addition to the traditional focus of the former Sugar Museum, which concentrated on the production, use and social history of cane and beet sugars, the newly opened exhibition sheds light on the topic of sugar from entirely new perspectives.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7709551-ysl-beaute-forever-youth-liberator-serum/
For the first time a YSL skincare product joins the collection at a science museum. Glycobiology, the science of glycans applied to the skin and cosmetics pioneered by YSL Beauté with FOREVER YOUTH LIBERATOR SERUM, is now part of the Berlin Museum‘s newly inaugurated permanent exhibition dedicated to the central role played by glycans in the realm of life.
After being closed for renovations for three years, the Berlin-based Sugar Museum has reopened as part of the Deutsches Technikmuseum with an expanded exhibition about sugars: “Sugars and Beyond! Food – Matter – Energy”, from November 26, 2015. In addition to the traditional focus of the former Sugar Museum, which concentrated on the production, use and social history of cane and beet sugars, the newly opened exhibition sheds light on the topic of sugar from entirely new perspectives.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7709551-ysl-beaute-forever-youth-liberator-serum/
Imagine looking outside your home window and seeing a group of deer partying in your swimming pool or, in a twist on the Goldilocks children’s story, you found a bear has broken into your home and has been tasting the food left in your refrigerator? Scenarios similar to this are the basis of a new ad campaign launched by Farmers Insurance®, one of the nation’s largest insurer groups. The company’s new, We Know From Experience, advertising campaign kicks off today with two television spots and a new interactive website that humorously convey to consumers that Farmers, over its 87 year history, has helped customers recover from some of the most unique --- yet very real --- claims.
“The amazingly unlikely events we’ll be featuring in our new campaign are based on real claims experienced by our customers,” said Mike Linton, chief marketing officer for Farmers Insurance. “Through this new campaign we hope consumers realize that we know a thing or two about insurance and that our agents are ready to help consumers understand coverage options so consumers can select the coverages they want.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7585551-farmers-insurance-we-know-from-experience/
